Turkey Cancer Drug Proposal Swims Against Cost Control Tide
Executive Summary
The president of Turkey has announced a plan for the cost of all cancer drugs to be paid by the government without any contribution from patients, including products licensed for different indications but which might be used off-label. But the move would add to an already rising bill and seems to go against an established trend of cost control.